Flag Therapeutics

FLAG Therapeutics is an early-stage oncology company focused on the development of therapies based on two research product platforms – the Anti-Angiogenic/Anti-Tubulin (AA/AT) platform and the Folate-Targeted Anticancer (FTAC) therapeutic development platform.